These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 9884068

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Long-term changes in the muscarinic M1 receptor induced by instantaneous formation of wash-resistant xanomeline-receptor complex.
    De Lorme KC, Grant MK, Noetzel MJ, Polson SB, El-Fakahany EE.
    J Pharmacol Exp Ther; 2007 Dec; 323(3):868-76. PubMed ID: 17855477
    [Abstract] [Full Text] [Related]

  • 24. 5-HT1A receptor-mediated G protein activation assessed by [35S]GTPgammaS binding in rat cerebral cortex.
    Odagaki Y, Toyoshima R.
    Eur J Pharmacol; 2005 Oct 03; 521(1-3):49-58. PubMed ID: 16182280
    [Abstract] [Full Text] [Related]

  • 25. Native rat hippocampal 5-HT1A receptors show constitutive activity.
    Martel JC, Ormière AM, Leduc N, Assié MB, Cussac D, Newman-Tancredi A.
    Mol Pharmacol; 2007 Mar 03; 71(3):638-43. PubMed ID: 17167032
    [Abstract] [Full Text] [Related]

  • 26. Role of receptor protein and membrane lipids in xanomeline wash-resistant binding to muscarinic M1 receptors.
    Jakubík J, Tucek S, El-Fakahany EE.
    J Pharmacol Exp Ther; 2004 Jan 03; 308(1):105-10. PubMed ID: 14569060
    [Abstract] [Full Text] [Related]

  • 27. Differential effects of the 5-hydroxytryptamine (5-HT)1A receptor inverse agonists Rec 27/0224 and Rec 27/0074 on electrophysiological responses to 5-HT1A receptor activation in rat dorsal raphe nucleus and hippocampus in vitro.
    Corradetti R, Mlinar B, Falsini C, Pugliese AM, Cilia A, Destefani C, Testa R.
    J Pharmacol Exp Ther; 2005 Oct 03; 315(1):109-17. PubMed ID: 15951403
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells.
    Cembala TM, Sherwin JD, Tidmarsh MD, Appadu BL, Lambert DG.
    Br J Pharmacol; 1998 Nov 03; 125(5):1088-94. PubMed ID: 9846649
    [Abstract] [Full Text] [Related]

  • 30. Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232).
    Bymaster FP, Wong DT, Mitch CH, Ward JS, Calligaro DO, Schoepp DD, Shannon HE, Sheardown MJ, Olesen PH, Suzdak PD, Swedberg MD, Sauerberg P.
    J Pharmacol Exp Ther; 1994 Apr 03; 269(1):282-9. PubMed ID: 7909558
    [Abstract] [Full Text] [Related]

  • 31. Differential modulation by GTPgammaS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [3H]-WAY100,635.
    Newman-Tancredi A, Verrièle L, Millan MJ.
    Br J Pharmacol; 2001 Jan 03; 132(2):518-24. PubMed ID: 11159702
    [Abstract] [Full Text] [Related]

  • 32. SB 202026: a novel muscarinic partial agonist with functional selectivity for M1 receptors.
    Loudon JM, Bromidge SM, Brown F, Clark MS, Hatcher JP, Hawkins J, Riley GJ, Noy G, Orlek BS.
    J Pharmacol Exp Ther; 1997 Dec 03; 283(3):1059-68. PubMed ID: 9399977
    [Abstract] [Full Text] [Related]

  • 33. Pharmacological analysis of G-protein activation mediated by guinea-pig recombinant 5-HT1B receptors in C6-glial cells: similarities with the human 5-HT1B receptor.
    Pauwels PJ, Wurch T, Palmier C, Colpaert FC.
    Br J Pharmacol; 1998 Jan 03; 123(1):51-62. PubMed ID: 9484854
    [Abstract] [Full Text] [Related]

  • 34. Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist.
    Heinrich JN, Brennan J, Lai MH, Sullivan K, Hornby G, Popiolek M, Jiang LX, Pausch MH, Stack G, Marquis KL, Andree TH.
    Eur J Pharmacol; 2006 Dec 15; 552(1-3):36-45. PubMed ID: 17056032
    [Abstract] [Full Text] [Related]

  • 35. Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity.
    Monte AP, Marona-Lewicka D, Lewis MM, Mailman RB, Wainscott DB, Nelson DL, Nichols DE.
    J Med Chem; 1998 Jun 04; 41(12):2134-45. PubMed ID: 9622555
    [Abstract] [Full Text] [Related]

  • 36. G(q/11) and G(i/o) activation profiles in CHO cells expressing human muscarinic acetylcholine receptors: dependence on agonist as well as receptor-subtype.
    Akam EC, Challiss RA, Nahorski SR.
    Br J Pharmacol; 2001 Feb 04; 132(4):950-8. PubMed ID: 11181437
    [Abstract] [Full Text] [Related]

  • 37. Allosteric modulation of 5-HT(1A) receptors by zinc: Binding studies.
    Barrondo S, Sallés J.
    Neuropharmacology; 2009 Feb 04; 56(2):455-62. PubMed ID: 18951909
    [Abstract] [Full Text] [Related]

  • 38. M1 receptor agonist activity is not a requirement for muscarinic antinociception.
    Sheardown MJ, Shannon HE, Swedberg MD, Suzdak PD, Bymaster FP, Olesen PH, Mitch CH, Ward JS, Sauerberg P.
    J Pharmacol Exp Ther; 1997 May 04; 281(2):868-75. PubMed ID: 9152396
    [Abstract] [Full Text] [Related]

  • 39. Differential effects on [35S]GTPgammaS binding using muscarinic agonists and antagonists in the gerbil brain.
    Pilar-Cuéllar F, Paniagua MA, Mostany R, Pérez CC, Fernández-López A.
    J Chem Neuroanat; 2005 Oct 04; 30(2-3):119-28. PubMed ID: 16095872
    [Abstract] [Full Text] [Related]

  • 40. Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: receptor subtype selectivity via cooperativity rather than affinity.
    Lazareno S, Dolezal V, Popham A, Birdsall NJ.
    Mol Pharmacol; 2004 Jan 04; 65(1):257-66. PubMed ID: 14722259
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.